Explorer
Bharat Biotech
India
Covaxin Phase 3 Trial Data Shows 77.8% Efficacy, Gets Approval From DCGI's Expert Panel
India
Covaxin Supplies At Rs 150/Dose ‘Non-Competitive Price, Not Sustainable’: Bharat Biotech Defends Higher Price
Health
No Emergency Use Approval For Covaxin In US; Phase 3 Trial Data Expected To Be Published In 7-8 Days, Says Dr VK Paul
Health
Covid Vaccine Prices To Be Revised, Centre In Talks With Serum Institute & Bharat Biotech: Sources
India
Early Covaxin Study Shows Protections Against Beta & Delta Variants Of Covid-19
Health
Covishield Elicits Better Antibody Response Than Covaxin: Study
India
AIIMS Delhi To Begin Covaxin Trials On Children Today Amid Third Wave Scare
Health
Biological E’s Corbevax At Rs 250/Dose May Be Cheapest Covid-19 Vaccine In India
Health
'More Info Required': WHO To Bharat Biotech As It Submits ‘90% Documents’ For Emergency Use Listing Of Covaxin
India
'Why Is Centre Preventing Bharat Biotech From Sharing Vaccine Formula If They Are Ready?': CM Kejriwal
India
Delhi HC Refuses to Stay Covaxin Clinical Trial On Children; Issues Notice to Centre, DGCI
Health
Covaxin Effective Against Covid Variants Found In India & UK: Bharat Biotech
Advertisement
Advertisement
Top Headlines
Cities
EC Releases Assam Draft Rolls After Special Revision, 10.5 Lakh Voter Names Deleted
India
Supreme Court Takes Suo Moto Cognisance On Aravalli Case, Hearing On Monday
India
CWC Meet Flags G RAM G Bill, SIR, Bangladesh As Kharge Announces MGNREGA Agitation
World
7.0 Magnitude Earthquake Hits Taiwan’s Yilan, Damage Assessment Underway
